abstract |
The present invention relates to tripeptide compounds, compositions containing said compounds, and methods of using said compounds in the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing said analogs, and methods of using these analogs in the treatment of HCV infection. |